SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Xeris Pharmaceuticals Q1 EPS $(0.890) Up From $(1.070) YoY

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.890) per share. This is a 16.82 percent increase over losses of $(1.070) per share from the same period last year.

Benzinga · 05/07/2020 11:11

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.890) per share. This is a 16.82 percent increase over losses of $(1.070) per share from the same period last year.